BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18669448)

  • 21. Predictive models in colorectal liver metastases--can we personalize treatment and outcome?
    Welsh FK; Tekkis PP; John TG; Rees M
    Dig Surg; 2008; 25(6):406-12. PubMed ID: 19212112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage plasmapheresis for small-for-size syndrome following hepatic resection for colorectal liver metastases.
    Sotiropoulos GC; Lang H; Herget-Rosenthal S; Molmenti EP; Baba HA; Karaliotas C; Broelsch CE; Saner FH
    Int J Colorectal Dis; 2008 May; 23(5):553. PubMed ID: 18060418
    [No Abstract]   [Full Text] [Related]  

  • 23. Survival and recurrence after neo-adjuvant chemotherapy and liver resection for colorectal metastases: a ten year study.
    Karanjia ND; Lordan JT; Fawcett WJ; Quiney N; Worthington TR
    Eur J Surg Oncol; 2009 Aug; 35(8):838-43. PubMed ID: 19010633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of liver metastases of colorectal cancers: how far should we go?].
    Penna C; Nordlinger B
    Gastroenterol Clin Biol; 1998 Dec; 22(12):1046-7. PubMed ID: 10051979
    [No Abstract]   [Full Text] [Related]  

  • 25. A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603.
    Kanemitsu Y; Kato T; Shimizu Y; Inaba Y; Shimada Y; Nakamura K; Sato A; Moriya Y;
    Jpn J Clin Oncol; 2009 Jun; 39(6):406-9. PubMed ID: 19389795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
    Benoist S; Nordlinger B
    Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metastatic colorectal carcinoma: clinicopathological downstaging following neoadjuvant chemotherapy.
    Janes S
    N Z Med J; 2005 Feb; 118(1210):U1321. PubMed ID: 15776097
    [No Abstract]   [Full Text] [Related]  

  • 28. [Liver resection. I].
    Oldhafer KJ; Stavrou GA
    Zentralbl Chir; 2006 Oct; 131(5):W54-66; quiz W67-8. PubMed ID: 17089283
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of the surgeon as a variable in long-term survival after liver resection for colorectal metastases.
    Giuliante F; Ardito F; Vellone M; Ranucci G; Federico B; Giovannini I; Nuzzo G
    J Surg Oncol; 2009 Dec; 100(7):538-45. PubMed ID: 19722234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to chemotherapy predicts survival following resection of hepatic colo-rectal metastases in patients treated with neoadjuvant therapy.
    Small RM; Lubezky N; Shmueli E; Figer A; Aderka D; Nakache R; Klausner JM; Ben-Haim M
    J Surg Oncol; 2009 Feb; 99(2):93-8. PubMed ID: 19065637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radiofrequency ablation of colorectal liver metastases].
    Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
    Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant chemotherapy and targeted therapy in patients with liver metastases from colorectal cancer; medical oncologist's point of view.
    Mihaylova Zh; Raynov J
    J BUON; 2008; 13(3):323-31. PubMed ID: 18979545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The patient behind the code, the care behind the patient.
    Vauthey JN; Zorzi D
    Cancer; 2009 Feb; 115(4):702-3. PubMed ID: 19127555
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatic veno-occlusive disease after neoadjuvant treatment of colorectal liver metastases with oxaliplatin: a lesson of the month.
    Schouten van der Velden AP; Punt CJ; Van Krieken JH; Derleyn VA; Ruers TJ
    Eur J Surg Oncol; 2008 Mar; 34(3):353-5. PubMed ID: 17207961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of margin width on outcome after resection of colorectal liver metastases.
    Bedi MM; Ramesh H
    Ann Surg; 2008 May; 247(5):905; author reply 905-6. PubMed ID: 18438137
    [No Abstract]   [Full Text] [Related]  

  • 36. Strategies to convert to resectability the initially unresectable colorectal liver metastases.
    Popescu I; Alexandrescu S; Croitoru A; Boros M
    Hepatogastroenterology; 2009; 56(91-92):739-44. PubMed ID: 19621694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver resection of colorectal metastases and adjuvant chemotherapy: can published data really support clinicians in clinical practice?
    Tamburini E; Tassinari D; Nicoletti S; Ravaioli A
    Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):84-5. PubMed ID: 19864119
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatic lymph node dissection provides a survival benefit for patients with nodal disease of colorectal carcinoma liver metastases.
    Wakai T; Shirai Y; Sakata J; Nagahashi M; Kaneko K; Hatakeyama K
    Hepatogastroenterology; 2009; 56(89):186-90. PubMed ID: 19453055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncologic results of laparoscopic versus open hepatectomy for colorectal liver metastases in two specialized centers.
    Castaing D; Vibert E; Ricca L; Azoulay D; Adam R; Gayet B
    Ann Surg; 2009 Nov; 250(5):849-55. PubMed ID: 19801934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic colorectal metastasis: current surgical therapy, selection criteria for hepatectomy, and role for adjuvant therapy.
    Fong Y
    Adv Surg; 2000; 34():351-81. PubMed ID: 10997228
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.